""Receiving the Kimberly Prize is a tremendous honor. It gave me an opportunity to visit Northwestern and experience the science happening here, which is outstanding and inspiring. It also gives me an opportunity to tell you more about my work.""
""Today, we are celebrating the awesome power of biochemistry and molecular genetics and the fact that there are no advancements in medicine without it.""
Svetlana Mojsov delivered the 2026 Kimberly Prize Lecture, highlighting her groundbreaking research on glucagon-like peptide-1 (GLP-1) and its impact on diabetes and obesity treatment. Her early discoveries in peptide synthesis and hormone biology established GLP-1 as a crucial incretin hormone, leading to the development of new therapeutic medicines. GLP-1-based drugs, such as Ozempic and Wegovy, are now widely used by millions for managing Type 2 diabetes and obesity. Mojsov's work exemplifies the significant advancements in medicine driven by biochemistry and molecular genetics.
Read at News Center
Unable to calculate read time
Collection
[
|
...
]